EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Myoarthropathic Symptoms Associated With Temporomandibular Disorders—A Pilot Randomised Controlled Trial

Lea S Prott iD, Vanessa Kaldenhoven, Alfons Hugger, Robert Langner, Petra C Gierthmuehlen, Mortimer Gierthmuehlen

Journal of Oral Rehabilitation · 2025

DOI: 10.1111/joor.70039 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Oral Rehabilitation, 2025. Verfasst von Lea S Prott und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany. Hauptthemen laut MEDLINE: Temporomandibular Joint Disorders, Transcutaneous Electric Nerve Stimulation, Vagus Nerve Stimulation, Chronic Pain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DGFDT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transcutaneous auricular vagus nerve stimulation (taVNS) is a safe and feasible treatment for a variety of acute and chronic pain conditions. However, no evidence about taVNS effectiveness in patients with chronic pain associated with temporomandibular disorders (TMD) is available.

Objective

To evaluate the feasibility of and compliance with taVNS in participants experiencing chronic TMD pain and potential effects on pain, psychological well‐being, muscle activity, and kinematics.

Methods

Twenty adults with chronic TMD pain were randomised to receive taVNS ( n = 10) or sham ( n = 10). In the taVNS group, stimulation was performed on the left tragus for 4 h daily (25 Hz, pulse width 250 μs, 28 s on/32 s off). In the sham group, an inactive non‐functional sham electrode was used. Patient‐reported outcome measures (GCPS, PHQ‐9, GAD‐7, PHQ‐15, and OHIP‐G14), muscle activity, and kinematics were assessed at baseline, 4 weeks, and 8 weeks. Compliance was assessed using a smartphone app, which recorded daily stimulation time and intensity.

Results

Recruitment and retention rates were high (100% and 90%, respectively), with 83% adherence to the intervention. Participants receiving taVNS showed a large effect on oral health‐related quality of life, and at least a small but potentially important effect on pain intensity, anxiety, depression, severity of somatic symptoms, muscle activity, and kinematics. However, none of these differences were statistically significant. No serious adverse events were identified. Conclusion taVNS proved feasible in participants with chronic TMD pain, suggesting potential benefits for symptom management. Future studies with larger sample sizes and extended follow‐up durations are necessary to confirm efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Temporomandibular Joint DisordersTranscutaneous Electric Nerve StimulationVagus Nerve StimulationChronic PainFacial PainHumansFemaleMalePilot ProjectsAdultTreatment OutcomeMiddle AgedPain MeasurementQuality of LifeFeasibility Studies

Stichwörter der Autor:innen

myofascial painneuromodulationtemporomandibular disorderstranscutaneous auricular vagus nerve stimulationvagus nervevagus nerve stimulation

Autor:innen und Institutionen

  • Department of Prosthodontics, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
  • Institute of Systems Neuroscience, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf Germany, Düsseldorf, Germany.
  • Institute of Neuroscience and Medicine, Brain and Behavior (INM-7), Research Center Jülich, Jülich, Germany.
  • Department of Neurosurgery, University Medical Center Knappschaftskrankenhaus Bochum GmbH, Bochum, Germany.

ORCID-Profile: Lea S Prott

Förderung

  • DGFDT

Zitieren

APA

Prott, L. S., Kaldenhoven, V., Hugger, A., Langner, R., Gierthmuehlen, P. C., & Gierthmuehlen, M. (2025). Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Myoarthropathic Symptoms Associated With Temporomandibular Disorders—A Pilot Randomised Controlled Trial. Journal of Oral Rehabilitation. https://doi.org/10.1111/joor.70039

Vancouver

Prott LS, Kaldenhoven V, Hugger A, Langner R, Gierthmuehlen PC, Gierthmuehlen M. Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Myoarthropathic Symptoms Associated With Temporomandibular Disorders—A Pilot Randomised Controlled Trial. Journal of Oral Rehabilitation. 2025. doi:10.1111/joor.70039

BibTeX
@article{Prott2025,
  author = {Prott, Lea S and Kaldenhoven, Vanessa and Hugger, Alfons and Langner, Robert and Gierthmuehlen, Petra C and Gierthmuehlen, Mortimer},
  title = {Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Myoarthropathic Symptoms Associated With Temporomandibular Disorders—A Pilot Randomised Controlled Trial},
  journal = {Journal of Oral Rehabilitation},
  year = {2025},
  doi = {10.1111/joor.70039}
}
Kostenlos starten →